BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

VertiFlex Sells Certain Assets to Stryker Corporation  (SYK)


3/14/2013 7:05:59 AM

SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- VertiFlex®, Inc., a leading innovator of advanced minimally invasive spinal surgery technologies, today announced the sale of certain assets to Stryker Corporation’s Spine Division relating to spinal implants that are not core to the ongoing strategic operations of the company. The scale and scope of the deal are not disclosed, however, the transaction provides VertiFlex with significant non-dilutive funding to further advance its platform for minimally invasive treatment of spinal stenosis.

“The sale of these innovative assets to Stryker represents the beginning of a new era in our relationships with strategic partners,” said Earl R. Fender, President and Chief Executive Officer of VertiFlex, Inc. “The agreement with Stryker includes up-front cash, contingent payments as well as a long-term licensing agreement. I’m very proud of the VertiFlex team. In addition to enrolling the largest ever FDA PMA trial of a device for spinal stenosis, we’ve also demonstrated proficiency in developing differentiated products for spinal therapies. The assets sold to Stryker are representative of such innovation.”

About VertiFlex®, Inc.

VertiFlex® is a privately held medical device company dedicated to the advancement of minimally invasive solutions for the treatment of lumbar spinal stenosis, which is the leading cause of spinal surgery in the elderly. Founded in 2005 and headquartered in San Clemente, CA, VertiFlex® has developed a proprietary, minimally invasive interspinous access platform for performing both indirect and direct decompressions of the lumbar spine. These technologies fill the MIS procedural gap in the stenosis treatment continuum between conservative care and traditional spine surgery. This provides new options for interventional spine physicians and less invasive options for traditional spine surgeons to treat patients who would otherwise undergo more invasive surgery. To date, VertiFlex® has compiled the largest, most rigorous, body of device clinical evidence, related to lumbar spinal stenosis.

Contact:

VertiFlex®, Inc.

Scott Lynch, 949-940-1400

info@vertiflexspine.com

www.vertiflexspine.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES